Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
COA
Hemab Therapeutics Holdings, Inc.
COAG
Return on equity
Return on equity at other companies
Synopsys
SNPS
3.8%
-21.5pp
Northern Trust
NTRS
14.5%
-3.2pp
Nucor
NUE
11.2%
+4.7pp
Dycom Industries
DY
19.7%
-0.1pp
Barnes Group
B
-3%
-4.9pp
Applied Materials
AMAT
39.7%
+3.3pp
Other financials
Income statement
See full
Operating income
-$26.1M
-62.4%
Net income
-$24.2M
-97.8%
EPS (diluted)
-$0.80
+93.8%
Balance sheet
See full
Cash & equivalents
$237.4M
—
Total debt
$1.0M
—
Total equity
$454.3M
+421%
Total assets
$467.8M
—
Cash flow
See full
Operating cash flow
-$22.6M
-47.6%
CapEx
$23.0K
—
Free cash flow
-$22.7M
-47.8%
Valuation
See full
Market cap
$2.32B
+107%
Enterprise value
$2.08B
—
Returns & leverage
See full
Debt / equity
0×
—
Current ratio
35.8×
—
Watchlist
Screener
Filings
Earnings
Charts